✦ LIBER ✦

Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome

✍ Scribed by Winfried Häuser; Frank Petzke; Claudia Sommer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability, and efficacy of mi

✍ L. Bateman; A. Spera; R. Palmer; J. Trugman; J. Lin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 32 KB

MA3 Comparative Outcomes of Fibromyalgia

✍ P. Sun; X. Peng; S. Sun; D. Novick; D. Faries; J. Andrews; A. Wu; M. Wohlreich 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Long-Term Safety, Tolerability, and Effi

✍ Philip J. Mease; I. Jon Russell; Daniel K. Kajdasz; Curtis G. Wiltse; Michael J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB

(170) Milnacipran is safe and well toler

✍ J. Gendreau; R. Palmer; K. Thacker 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Comparison of milnacipran, duloxetine an

✍ L. Bardin; S. Gregoire; M. Aliaga; N. Malfetes; O. Vitton; P. Ladure; A. Newman- 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 350 KB

(384) Evaluation of efficacy of duloxeti

✍ Rahimzadeh, P.; Faiz, S.; Imani, F.; Alebouyeh, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 91 KB